Taymour Hammoudi, MD, PhD

Professional Titles

• Assistant Professor
• BMT/CT Physician

Recognitions

• Page Scholar, Center for International Blood and Marrow Transplant Research (CIBMTR) (2025)
  The CIBMTR Page Scholars Program is a two-year initiative designed to immerse early-career investigators (typically 3-7 years post-fellowship) in the workings of CIBMTR’s Working Committees, giving them mentorship, leadership exposure, data-access experience and roles in protocol oversight. The program was launched in 2023 (initially called the Working Committee Training & Leadership Program), and was renamed in honor of the late Kristin Page Chartrand to reflect her dedication to career development and research leadership.
• Robert J Leftkowitz Society for Physician Scientists, Member, Duke University School of Medicine (2022)
  The Robert J. Lefkowitz Society at Duke University School of Medicine provides a supportive community for MD and MD/PhD residents and fellows who are pursuing careers as physician-investigators focused on basic and translational research. Membership is by selection (5-10 new members annually), includes mentorship with senior physician-scientists, networking events (including dinners), and opportunities for scientific and career development throughout one’s training.
• Pediatric Research Scholar, Duke University School of Medicine (2021)
  The Duke Pediatric Research Scholars Program (DPRS) at Duke University School of Medicine is a physician-scientist training pathway designed to help pediatric residents and fellows transition into academic investigator roles, by combining intensive clinical training at Duke Children’s Hospital & Health Center with robust research experiences in Duke’s laboratories. Participants receive concierge mentoring, professional development seminars, scholarly engagement opportunities, and research support including funding and travel for presentations.
• T32 Training Award, Research Training in Childhood Cancer, National Cancer Institute, NIH (2018)
  The T32 CA128583 training award from the National Cancer Institute (NCI) supports a structured pre-doctoral and/or post-doctoral training program in Translational Cancer Biology (TCB), with the primary goal of preparing trainees to become independent investigators capable of conducting high-impact cancer research. The program emphasizes rigorous coursework, mentored research in relevant biological models, interdisciplinary collaboration, and exposure to the full translational spectrum from molecular mechanisms to clinical applications.

Research Interests

Publications

• Hammoudi T, Nucera S MD, Troullioud Lucas AG, Ansari M, Balduzzi AC, Bertaina A, Buechner J, Corbacioglu S, Dalle JH, Kalwak K, Lee DAA, Levine JE, Lindemans CA, Locatelli F, Meisel R, Nierkens S, Ottaviano G, Perez-Martinez A, Pichler H, Prockop SE, Pulsipher MA, Talano JM, Tewari S, Schultz KR, Shah NN, Vernaris M, Boelens JJ. Harmonized Immune Recovery Monitoring after HCT: Evidence & Practical Guidance from the Westhafen Intercontinental Group. Blood Adv. 2025 Sep 3:bloodadvances.2025016915. doi: 10.1182/bloodadvances.2025016915. Epub ahead of print. PMID: 40902074.
• Hammoudi T, Nucera S MD, Troullioud Lucas AG, Ansari M, Balduzzi AC, Bertaina A, Buechner J, Corbacioglu S, Dalle JH, Kalwak K, Lee DAA, Levine JE, Lindemans CA, Locatelli F, Meisel R, Nierkens S, Ottaviano G, Perez-Martinez A, Pichler H, Prockop SE, Pulsipher MA, Talano JM, Tewari S, Schultz KR, Shah NN, Vernaris M, Boelens JJ. Harmonized Immune Recovery Monitoring after HCT: Evidence & Practical Guidance from the Westhafen Intercontinental Group. Blood Adv. 2025 Sep 3. [Epub ahead of print] PubMed PMID: 40902074
• Combes AJ, Samad B, Tsui J, Chew NW, Yan P, Reeder GC, Kushnoor D, Shen A, Davidson B, Barczak AJ, Adkisson M, Edwards A, Naser M, Barry KC, Courau T, Hammoudi T, Argüello RJ, Rao AA, Olshen AB, Cai C, Zhan J, Davis KC, Kelley RK, Chapman JS, Atreya CE, Patel A, Daud AI, Ha P, Diaz AA, Kratz JR, Collisson EA, Fragiadakis GK, Erle DJ, Boissonnas A, Asthana S, Chan V, Krummel MF. Discovering dominant tumor immune archetypes in a pan-cancer census. Cell. 2022 Jan 6;185(1):184-203.e19. PubMed PMID: 34963056
• Rinker TE, Hammoudi TM, Kemp ML, Lu H, Temenoff JS. Interactions between mesenchymal stem cells, adipocytes, and osteoblasts in a 3D tri-culture model of hyperglycemic conditions in the bone marrow microenvironment. Integr Biol (Camb). 2014 Mar;6(3):324-37. PubMed PMID: 24463781
• Hamilton SK, Bloodworth NC, Massad CS, Hammoudi TM, Suri S, Yang PJ, Lu H, Temenoff JS. Development of 3D hydrogel culture systems with on-demand cell separation. Biotechnol J. 2013 Apr;8(4):485-95. PubMed PMID: 23447378
• Hammoudi, Taymour Marwan. 3D micropatternable hydrogel systems to examine crosstalk effects between mesenchymal stem cells, osteoblasts, and adipocytes. Diss. Georgia Institute of Technology, 2012.
• Hammoudi TM, Rivet CA, Kemp ML, Lu H, Temenoff JS. Three-dimensional in vitro tri-culture platform to investigate effects of crosstalk between mesenchymal stem cells, osteoblasts, and adipocytes. Tissue Eng Part A. 2012 Aug;18(15-16):1686-97. PubMed PMID: 22472084
• Lim JJ, Hammoudi TM, Bratt-Leal AM, Hamilton SK, Kepple KL, Bloodworth NC, McDevitt TC, Temenoff JS. Development of nano- and microscale chondroitin sulfate particles for controlled growth factor delivery. Acta Biomater. 2011 Mar;7(3):986-95. PubMed PMID: 20965281
• Hammoudi, Taymour M., and Johnna S. Temenoff. Biomaterials for regeneration of tendons and ligaments. Springer Vienna, 2011.
• Hammoudi TM, Lu H, Temenoff JS. Long-term spatially defined coculture within three-dimensional photopatterned hydrogels. Tissue Eng Part C Methods. 2010 Dec;16(6):1621-8. PubMed PMID: 20412031

Practice Locations

• Children's Hospital Colorado

• Colorado Clinical & Translational Sciences Institute (CCTSI)

Specialty Information

• Pediatrics, Board Certification (2019)
• Pediatric Hematology / Oncology, Board Certification (2021)
• Physician License, Colorado Medical Board, License (2023)
• Physician License, New Mexico Medical Board, License (2024)
• Physician License, Montana Medical Board, License (2024)
• Physician License, Nebraska Medical Board, License (2025)

• Cancers - Blood and Marrow Transplant
• Cancers
• Cancers - Cancer Medicine
• Cancers - Pediatric Cancer